Boston Scientific claims win in Johnson & Johnson dispute

By Associated Press May 8, 2008 Comments (0)

0 Recommendations

Medical device maker Boston Scientific Corp. said Thursday a Canadian court dismissed a patent infringement lawsuit filed against the company by rival Johnson & Johnson.

New Brunswick, N.J.-based Johnson & Johnson sued Natick, Mass.-based Boston Scientific, claiming its NIR stents infringed two of Johnson & Johnson's patents. The court ruled that one Johnson & Johnson patent was not infringed and the other patent was invalid.

Johnson & Johnson is also suing Boston Scientific over its Express and Taxus Express stents.

Stents are tiny, mesh-wire tubes that prop open arteries after they have been surgically cleared of fatty plaque.

Johnson & Johnson could not immediately be reached for comment late Thursday.

Shares of Boston Scientific rose 26 cents to close at $13.68.

Shares of Johnson & Johnson fell a penny to close at $66.90.

Comments (0)

Comments from our Foolish Readers

Help us Keep this a Respectfully Foolish Area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.